Login

Timothy Morris - CFO, Head of Business Development, AcelRx Pharmaceuticals Inc 00:00:00

Share On Facebook Share On Twitter

Discuss the specialty pharmaceutical company

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Honoring Pamela's Extraordinary Climbing Achievements and Family Connection
00:10:00
4GLOBAL CEO Eloy Mazon Discusses Interim Results and AI-Driven Growth | Eloy Mazon, CEO, 4GLOBAL PLC.
00:10:00
Patriot Lithium’s Gorman Project Yields Promising Results: CEO Nicholas Vickery Shares Insights | Nick Vickery ,CEO , Patriot Lithium Ltd.
00:10:00
From Building Brands To Creating Movements|Jyri Engeström,Partner and Early-Stage to Pre-IPO Investor,Yes VC
00:10:00
Greg Gilbert: Enhancing Institutional Investment through OCIO Services | Greg Gilbert - CEO of Americas Institutional at Russell Investments
00:10:00
building infrastructure and applications for the next generation of financial services|Daniel Kimerling,Managing Partner,Deciens Capital
00:10:00
Last week, SpartanNash CEO Tony Sarsam discussed business insights with CNBC Mad Money, referencing Casella Waste Systems.
00:10:00
Tomagold's Promising Drilling Results and Expansion at Shibagama Complex
00:10:00
Perennial Global Resources Trust Portfolio Manager Sam Berg Discusses Fund's Strategy
00:10:00
Orlando Bravo and Carl Thoma Reflect on Culture and Success in Private Equity | Orlando Bravo, Founder, Thoma Bravo.
00:10:00
Expanding Global Horizons: Insights from Qureshi Corporation’s Recruitment for BINGHATTI Construction in Dubai | Qureshi Corporation - Recruitment Partner for BINGHATTI
00:10:00
Taruga Minerals: Exploring High-Grade Cobalt Deposits in Congo

© 2026 Nehu